Rankings
▼
Calendar
LXRX Q2 2018 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$693M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+14.1% YoY
Gross Profit
$13M
93.9% margin
Operating Income
-$30M
-221.3% margin
Net Income
-$35M
-252.4% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
-45.4%
Cash Flow
Operating Cash Flow
-$53M
Free Cash Flow
-$53M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$333M
Total Liabilities
$338M
Stockholders' Equity
-$5M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$12M
+14.1%
Gross Profit
$13M
$12M
+12.1%
Operating Income
-$30M
-$34M
+10.2%
Net Income
-$35M
-$35M
+1.0%
← FY 2018
All Quarters
Q3 2018 →